Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1975;46:308-310
© 1975 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROLAND, M.
Right arrow Articles by KANE, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROLAND, M.
Right arrow Articles by KANE, R.

Further Study of d-Norgestrel for Fertility Control

MAXWELL ROLAND, MD, FACOG, DAVID LEISTEN, MD, FACOG and ROLF KANE, MD

From the Department of Obstetics and Gynecology at the French and Polyclinic Mlcdical School and Health Center. New York. New York.

Abstract

In a continuing oral contraceptite study of d-norgestrd, the 1.11mg dose—the dose presiouslr found to give the best cycle control—was administered cyclically on a "21–7 dat" schedule to 284 women during 2650 cycles. None of the women conceited, and cycle control, though often altered, was generally acceptable. Side effects were minimal, and laboratoy determinations performed prior to and during the administration of this agent revealed no clinically significant changes.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American College of Obstetricians and Gynecologists.